EyeSonix Overview
- Year Founded
-
2006

- Status
-
Private
- Employees
-
3

- Latest Deal Type
-
Grant
- Investors
-
1
EyeSonix General Information
Description
Developer of an ultrasound therapeutic device designed to treat glaucoma. The company uses low-power ultrasound to treat glaucoma and that has the potential to offer neuroprotection to halt or reduce damage to the optic nerve beyond the decrease in intraocular pressure, enabling clinicians with a transformative method to treat glaucoma.
Contact Information
Website
www.eyesonix.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Primary Office
- 10380 Wilshire Boulevard
- Suite 1404
- Los Angeles, CA 90024
- United States
+1 (562) 000-0000
EyeSonix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Grant | 01-Jan-2013 | 00000 | Completed | Generating Revenue | ||
1. Angel (individual) | 00000 | 00000 | Completed | Startup |
EyeSonix Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Eric Schultz | Co-Founder, Chief Executive Officer & Chief Technology Officer | ||
Donald Schwartz MD | Co-Founder & President |
EyeSonix Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Sharon Bakalash MD | Self | Board Member | 000 0000 |
EyeSonix Signals
EyeSonix Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Western Glaucoma Foundation | Other | 000 0000 | 000000 0 |